Rossari Biotech Ltd

Fri 16/10/2026,14:59:56 | NSE : ROSSARI

₹453.5516.40 (3.75%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 437.15

Previous Close

₹ 437.15

Volume

97025

Mkt Cap ( ₹ Cr)

₹ 2512.40

High

₹ 459.80

Low

₹ 432.45

52 Week High

₹ 690.30

52 Week Low

₹ 375.00

Book Value Per Share

₹ 246.96

Dividend Yield

0.11

Face Value

₹ 2.00

What's Your Call?

Collective community sentiment on Rossari Biotech Ltd

Your Vote -

Buy

28.66%

Hold

46.15%

Sell

25.19%

28.66%

663 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

50%

Sell Order Quantity

50%

Bid Price

Qty

454.40

22

454.00

9

454.00

21

454.00

323

454.00

32

Bid Total

29305

Bid Price

Qty

454.60

1

455.00

16

455.00

80

455.00

64

455.00

92

Bid Total

28991

Option Chain

Analyzes market sentiment, predicts Rossari Biotech Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    14 Oct 2026, 6:58PM Intimation of Earnings Conference Call for investor and analyst on Monday, October 19, 2026 at 04:00 P.M. (IST).

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    14 Oct 2026, 6:49PM Intimation of Earnings Conference Call for investor and analyst on Monday, October 19, 2026 at 04:00 P.M. (IST).

  • Rossari Biotech has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    13 Oct 2026, 8:22PM As of September 2026, 68.14% is owned by Promoters and 31.86% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 63.63% and

  • Rossari Biotech - Board Meeting Intimation for Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Ha

    9 Oct 2026, 7:52PM Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2026 ,inter alia, to consider and

  • Rossari Biotech - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    6 Oct 2026, 8:23PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

  • Rossari Biotech - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    6 Oct 2026, 8:19PM Compliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026

  • Rossari Biotech - Trading Window

    25 Sep 2026, 3:36PM Rossari Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    16 Sep 2026, 3:08PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    16 Sep 2026, 3:08PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    10 Sep 2026, 8:09PM Intimation of Analyst/Institutional Investors Meet/Con. Call/Updates.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    10 Sep 2026, 8:03PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Updates

    6 Aug 2026, 8:06PM Intimation of non-participation in the investors and analysts meet scheduled on Monday, August 10, 2026.

  • Rossari Biotech - Update On Investor Call.\r\n

    6 Aug 2026, 8:03PM Intimation of non-participation in the investors and analysts meet scheduled on Monday, August 10, 2026.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    3 Aug 2026, 7:56PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    3 Aug 2026, 7:56PM Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    24 Jul 2026, 8:31PM Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20, 2026.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Jul 2026, 8:26PM Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20, 2026.

  • Rossari Biotech has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    21 Jul 2026, 5:00PM As of June 2026, 68.14% is owned by Promoters and 31.86% by Public. <p align=justify> Among Promoters holding, Indian Promoters holds 63.63% and Forei

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Outcome of AGM

    20 Jul 2026, 9:51PM Outcome of 17th Annual General Meeting of the Members of the Company along with Proceedings, Voting Results and Scrutinizers Report.

  • Rossari Biotech - Shareholders meeting

    20 Jul 2026, 9:48PM Outcome of 17th Annual General Meeting of the Members of the Company along with Proceedings, Voting Results and Scrutinizers Report.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    20 Jul 2026, 9:26PM Audio recording of Earnings Conference Call for Q1 FY 27.

  • Rossari Biotech - Analysts/Institutional Investor Meet/Con. Call Updates

    20 Jul 2026, 9:26PM Audio recording of Earnings Conference Call for Q1 FY 27.

  • Rossari Biotech - Update On Grant Of Options.

    20 Jul 2026, 9:09PM Update on Grant of Options.

  • Rossari Biotech - ESOP/ESOS/ESPS

    20 Jul 2026, 9:08PM Update on Grant of Options

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Press Release

    19 Jul 2026, 4:30PM Rossari Biotech Limited informed the Exchange regarding Press Release dated July 18, 2026 titled "" Rossari Biotech announces Q1 FY 27 results"".

  • Rossari Biotech - Investor Presentation

    19 Jul 2026, 4:19PM Rossari Biotech Limited has informed the Exchange about Investor Presentation

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Investor Presentation

    19 Jul 2026, 4:19PM Intimation of Q1 FY27- Earnings Presentation.

  • Rossari Biotech - Copy of Newspaper Publication

    19 Jul 2026, 4:11PM Newspaper publication of extract of Consolidated Unaudited Financial Results for the Quarter ended June 30, 2026.

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    19 Jul 2026, 4:28PM Rossari Biotech Limited informed the Exchange regarding Press Release dated July 18, 2026 titled \ Rossari Biotech Limited announces Q1 FY 27 results\

  • Rossari Biotech - Intimation Under Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations, 2015

    18 Jul 2026, 5:02PM Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

  • Rossari Biotech - General Updates

    18 Jul 2026, 5:02PM Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015.

  • Rossari Biotech - Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan- 2019

    18 Jul 2026, 4:56PM Intimation of grant of 4000 options Under Rossari Employee Stock Option Plan - 2019

  • Rossari Biotech - ESOP/ESOS/ESPS

    18 Jul 2026, 4:56PM Intimation of grant of 4000 options under Rossari Employee Stock Option Plan - 2019.

  • Rossari Biotech - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

    18 Jul 2026, 4:49PM Intimation of allotment of 2500 Equity Shares under Rossari Employee Stock Option Plan - 2019

  • Rossari Biotech - Allotment of Securities

    18 Jul 2026, 4:49PM Intimation of allotment 2500 Equity shares under Rossari Employee Stock Option Plan -2019.

  • Rossari Biotech - Outcome of Board Meeting

    18 Jul 2026, 4:36PM Outcome of Board Meeting held on July 18, 2026.

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    20 Jul 2026, 10:04PM Scrutinizer's Report for the 17th Annual General Meeting of the Members of the Company.

  • Rossari Biotech - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026.

    18 Jul 2026, 4:47PM Unaudited Financial Results (standalone and consolidated) for the quarter ended June 30, 2026

  • Rossari Biotech - Board Meeting Outcome for Outcome Of Board Meeting Held On July 18, 2026.

    18 Jul 2026, 4:33PM Board Meeting held on Saturday, July 18, 2026

  • Rossari Biotech

    20 Oct 2022 , 10:21AM RBL has approved the incorporation of a wholly owned subsidiary in Bangladesh with an estimate aggregate Capital outlay of BDT 300 million (approximately Rs. 25 Crore). The Wholly Owned Subsidiary will enable the Company to expand the market for RBL products in Bangladesh. Positive for the stock

  • Rossari Biotech

    19 Jul 2021 , 10:22AM Rossari Biotech Limited (Rossari): The company has approved the acquisition of Tristar Intermediates Pvt. Ltd. As per the agreement, Rossari will be acquiring 100% of the equity share capital of Tristar Intermediates. 76% of the equity share capital will be acquired upon closure of the transaction, and the balance 24% over the next 3 years. The total enterprise value of the transaction is Rs. 120 crores. Rossari plans to fund the investment through cash on balance sheet and doesn’t intend to raise any debt for this acquisition. The transaction will add scale, provide cross-selling opportunities, and accelerate growth for Rossari, while significantly enhancing value creation in the longer term. The synergistic acquisition provides Rossari with enhanced portfolio of products, stronger presence in new & untapped international markets and access to newer technologies.

  • Rossari Biotech debuts at 58% premium

    23 Jul 2020 , 10:46AM Rossari Biotech lists at Rs. 670/Sh against the issue price of Rs. 425/Sh
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Rossari Biotech Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 1345.004 1107.318 1015.386 923.612 784.524
Liabilities 1345.004 1107.318 1015.386 923.612 784.524
Equity 11.077 11.073 11.049 11.031 11.011
Gross Profit 208.335 186.235 161.254 122.648 122.793
Net Profit 142.838 114.742 99.645 71.39 79.474
Cash From Operating Activities 58.729 92.198 73.918 113.66 33.116
NPM(%) 8.15 8.01 8.28 7.32 7.4
Revenue 1752.066 1431.628 1202.91 975.172 1072.844
Expenses 1543.731 1245.393 1041.656 852.524 950.051
ROE(%) 10.44 8.38 7.28 5.21 5.8

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
10 Jul 2026 0.5 25 0.11 504.2
20 Jun 2025 0.5 25 0.11 699.35
16 Aug 2024 0.5 25 0.11 780.3
24 May 2023 0.5 25 0.11 695.5
07 Jul 2022 0.5 25 0.11 888.75
08 Sep 2021 0.5 25 0.11 1282.15

Peers

Other companies within the same industry or sector that are comparable to Rossari Biotech Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Sameera Agro And Infra Ltd 4.15 0.00 1.70 519.98 24.38 0.00
Shreeoswal Seeds and Chemicals Ltd 11.87 1.54 8.86 3993.58 39.48 0.00
GRM Overseas Ltd 94.65 0.70 25.65 2619.60 179.39 0.00
Jain Irrigation Systems Ltd 27.02 0.00 0.00 32042.07 -17.22 0.00

Company Info

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 2021.-Rossari Biotech completed acquisition of 1st tranche of 76% stake of Tristar.2023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company.

The Promoters, commenced the specialty chemicals business on March 6, 2003, as a partnership firm in the name of `Rossari Labtech', having Mr. Edward Menezes and Mr. Sunil Chari as partners. Subsequently, on December 5, 2003, the name of the partnership firm was changed to `Rossari Biotech', and the business of the partnership was changed to that of manufacturing, purchase, sale, import, export and otherwise to deal in enzymes, textile auxiliaries, applications and products of biotechnology for textiles, leather, paper, construction materials, pharmaceuticals etc. Further, on January 17, 2004, RBIPL was admitted as partner in Rossari Biotech. On April 1, 2009, Ms. Anita Menezes, Ms. Usha Chari, Ms. Jyotishna Chari and late Ms. Irene Menezes were admitted as partners in Rossari Biotech and on June 15, 2009, Mr. Mikhail Menezes was admitted as a partner in Rossari Biotech.Major events and milestones :2003- The Promoters entered into a partnership firm to start the manufacturers of specialty chemicals and industrial enzymes in India2004- Established the first manufacturing facility at Silvassa2009- Conversion of partnership firm into the Company- Incorporation of the Company- Obtained recognition for in-house R&D unit from the Department of Scientific and Industrial Research2010- Forayed into animal health and nutrition products2013- Forayed into HPPC products2014- The Promoters entered into a Joint Venture with BUZIL-WERK Wagner GmbH & Co. KG to form Buzil Rossari Private Limited-Recipient of Best Innovator Award 2014 by BIRAC Govt.Of India2015- Lease granted by GIDC to the Company for setting up the manufacturing facility at Dahej2017- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 9001:2015- The Food Safety Management System of the Silvassa Manufacturing Facility has been assessed and found to conform to the requirements of ISO 14001:20152018- Entered into an exclusive purchasing agreement with Hindustan Unilever Limited2019-Rossari Biotech files Rs 700-cr IPO papers with Sebi2020- Completion of the Pre-IPO Placement2021-Rossari Biotech announces full commissioning of its Greenfield manufacturing facility at Dahej, Gujarat.-Rossari Biotech Ltd was recently bestowed with the Goldern Peacock Award for Business Excellence 2021.-Rossari Biotech completed acquisition of 1st tranche of 76% stake of Tristar.2023-Bio Spectrum India Excellence Awards 2023 as the Bet Indian Industrial Enzymes Company.

Parent Organisation

Rossari Biotech Ltd.

Founded

10/08/2009

Managing Director

Mr.Sunil Chari

NSE Symbol

ROSSARIEQ

FAQ